Enhancement and Analysis of Human Antiaflatoxin B1 (AFB1) scFv Antibody-Ligand Interaction Using Chain Shuffling

Journal of Agricultural and Food Chemistry
Kuntalee RangnoiMontarop Yamabhai

Abstract

A human antiaflatoxin B1 (AFB1) scFv antibody (yAFB1-c3), selected from a naı̈ve human phage-displayed scFv library, was used as a template for improving and analysis of antibody-ligand interactions using the chain-shuffling technique. The variable-heavy and variable-light (VH/VL)-shuffled library was constructed from the VH of 25 preselected clones recombined with the VL of yAFB1-c3 and vice versa. Affinity selection from these libraries demonstrated that the VH domain played an important role in the binding of scFv to free AFB1. Therefore, in the next step, VH-shuffled scFv library was constructed from variable-heavy (VH) chain repertoires, amplified from the naı̈ve library, recombined with the variable-light (VL) chain of the clone yAFB1-c3. This library was then used to select a specific scFv antibody against soluble AFB1 by a standard biopanning method. Three clones that showed improved binding properties were isolated. Amino acid sequence analysis indicated that the improved clones have amino acid mutations in framework 1 (FR1) and the complementarity determining region (CDR1) of the VH chain. One clone, designated sAFH-3e3, showed 7.5-fold improvement in sensitivity over the original scFv clone and was selected for molec...Continue Reading

References

Apr 4, 1997·Journal of Molecular Biology·G JonesR Taylor
Jun 1, 1996·Immunotechnology : an International Journal of Immunological Engineering·R A IrvingP J Hudson
Feb 19, 1998·Journal of Molecular Biology·V MoreaA M Lesk
Nov 10, 1998·Folding & Design·P Kristensen, G Winter
Dec 21, 2004·Nucleic Acids Research·Ida RetterWerner Müller
Jun 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Arvind RajpalRoberto Crea
Jan 31, 2006·Bioinformatics·Mahender Kumar SinghGrish C Varshney
Apr 20, 2006·Molecular Immunology·Alejandro López-RequenaRolando Pérez
Mar 27, 2007·Biotechnology Advances·Claudia SheedyJ Christopher Hall
Oct 1, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Thomas W KenslerJohn D Groopman
May 2, 2014·Nucleic Acids Research·Marco BiasiniTorsten Schwede

❮ Previous
Next ❯

Citations

Aug 22, 2021·Analytical and Bioanalytical Chemistry·Riikka PeltomaaMaría C Moreno-Bondi
Oct 12, 2021·ACS Omega·Kuntalee RangnoiMontarop Yamabhai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.